Literature DB >> 31655770

Primary Aldosteronism Diagnosis and Management: A Clinical Approach.

Gregory L Hundemer1, Anand Vaidya2.   

Abstract

Primary aldosteronism used to be considered a rare cause of secondary hypertension. However, accruing evidence indicates that primary aldosteronism is more common than previously recognized. The implications of this increased prevalence are important to public health because autonomous aldosterone production contributes to cardiovascular disease and can be treated in a targeted manner. This article focuses on clinical approaches for diagnosing primary aldosteronism more frequently and earlier in its course, as well as practical treatment objectives to reduce the risk for incident cardiovascular disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aldosterone; Cardiovascular disease; Cardiovascular morbidity; Hypertension; Primary aldosteronism

Mesh:

Year:  2019        PMID: 31655770      PMCID: PMC6824480          DOI: 10.1016/j.ecl.2019.08.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  128 in total

1.  CACNA1H mutations in autism spectrum disorders.

Authors:  Igor Splawski; Dana S Yoo; Stephanie C Stotz; Allison Cherry; David E Clapham; Mark T Keating
Journal:  J Biol Chem       Date:  2006-06-05       Impact factor: 5.157

2.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 3.  The SPARTACUS Trial: Controversies and Unresolved Issues.

Authors:  Felix Beuschlein; Paolo Mulatero; Evelyn Asbach; Silvia Monticone; Cristiana Catena; Leonardo A Sechi; Michael Stowasser
Journal:  Horm Metab Res       Date:  2017-11-17       Impact factor: 2.936

4.  Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.

Authors:  Thomas Arnesen; Nina Glomnes; Siri Strømsøy; Stian Knappskog; Anette Heie; Lars A Akslen; Marianne Grytaas; Jan Erik Varhaug; Oliver Gimm; Michael Brauckhoff
Journal:  Langenbecks Arch Surg       Date:  2013-06-19       Impact factor: 3.445

5.  Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.

Authors:  Sébastien Savard; Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

6.  Endothelial Mineralocorticoid Receptor Mediates Parenchymal Arteriole and Posterior Cerebral Artery Remodeling During Angiotensin II-Induced Hypertension.

Authors:  Janice M Diaz-Otero; Courtney Fisher; Kelsey Downs; M Elizabeth Moss; Iris Z Jaffe; William F Jackson; Anne M Dorrance
Journal:  Hypertension       Date:  2017-10-03       Impact factor: 10.190

Review 7.  Genetic Causes of Functional Adrenocortical Adenomas.

Authors:  Maria-Christina Zennaro; Sheerazed Boulkroun; Fabio Fernandes-Rosa
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

8.  Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.

Authors:  Julian C Y Ip; Tony C Y Pang; Cindy K Pon; Jing Ting Zhao; Mark S Sywak; Anthony J Gill; Patsy S Soon; Stan B Sidhu
Journal:  ANZ J Surg       Date:  2013-11-26       Impact factor: 1.872

9.  Long term outcome of Aldosteronism after target treatments.

Authors:  Vin-Cent Wu; Shuo-Meng Wang; Chia-Hui Chang; Ya-Hui Hu; Lian-Yu Lin; Yen-Hung Lin; Shih-Chieh Jeff Chueh; Likwang Chen; Kwan-Dun Wu
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

10.  CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism.

Authors:  Georgios Daniil; Fabio L Fernandes-Rosa; Jean Chemin; Iulia Blesneac; Jacques Beltrand; Michel Polak; Xavier Jeunemaitre; Sheerazed Boulkroun; Laurence Amar; Tim M Strom; Philippe Lory; Maria-Christina Zennaro
Journal:  EBioMedicine       Date:  2016-10-04       Impact factor: 8.143

View more
  1 in total

Review 1.  Pathophysiology of bilateral hyperaldosteronism.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.